Back to search

Dysis Medical Limited

04446534

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

OCTAGON POINT, LONDON, EC2V 6AA
Incorporated 24/05/2002

Compliance

Last accounts

31/12/2024

total exemption full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 17/02/2026

Due 03/03/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Christian Markussen

director · Since 04/02/2025

BUSINESS PERSON

DANISH · DENMARK · Age 60

Stig Pieler

director · Since 04/02/2025

BUSINESS PERSON

DANISH · DENMARK · Age 61

Persons with Significant Control

Apgar Danmark A/S

75–100% shares
75–100% votes

24, Ringager, Broendby

Reg: 17533533 · Denmark · Limited Liability Corporation

Notified 04/02/2025

Former PSCs

Lundbeckfond Invest A/S

Ceased 04/02/2025

Charges0 outstanding

Charge
satisfied

LUNDBECKFOND INVEST A/S

Created 24/04/2018Registered 02/05/2018Satisfied 01/08/2018
Charge
satisfied

KREOS CAPITAL V (UK) LIMITED

Created 30/11/2016Registered 15/12/2016Satisfied 10/03/2023
Charge
satisfied

ALBION ENTERPRISE VCT PLC AS SECURITY TRUSTEE (AS DEFINED IN THE INSTRUMENT EVIDENCING THE CHAR

Created 29/08/2016Registered 05/09/2016Satisfied 10/03/2023
Charge
satisfied

ALBION ENTERPRISE VCT PLC AS SECURITY TRUSTEE (AS DEFINED IN THE INSTRUMENT EVIDENCING THE CHAR

Created 05/04/2016Registered 07/04/2016Satisfied 10/03/2023
Charge
satisfied

SHAWBROOK BANK LIMITED

Created 18/06/2015Registered 02/07/2015Satisfied 26/04/2018
charge
satisfied

ALBION ENTERPRISE VCT PLC AS AGENT AND SECURITY TRUSTEE FOR EACH OF THE PARTICIPATING INVESTORS

Created 21/12/2012Registered 09/01/2013Satisfied 19/04/2013
charge
satisfied

NBG TECHNOLOGY LP

Created 02/08/2005Registered 17/08/2005Satisfied 06/03/2009

CompanyRankvs 65+ SIC 72110 peers
85

Financial strength84th percentile among SIC peers · 21/25
Employees95th percentile among SIC peers · 14/15
LiquidityCurrent ratio 40.19× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
65Dysis Medical Limited
85
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£196k

Balance sheet strength

Cash

£105k

Cash in the bank

Net Current Assets

£196k

Working capital

Current Assets

£201k

Current Liabilities

£5k

Debtors

£96k

15avg. employees

Balance Sheet

Assets less current liabilities£196k
Signed by Mr Christian Markussen Mr Stig Pieler 27/11/2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202440.19+£32.0M
20236.71—

Derived from filed accounts. Not audited figures.